Discover how ultra-early epilepsy surgeries transform the lives of children with drug-resistant seizures, preventing long-term brain damage.

Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.

An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

A large cohort study sheds new light on neurodevelopmental risk in children after prenatal antiseizure medication exposure, ...

Dravet syndrome affects about 1 in 17,500 children. Having two daughters with the condition is “extraordinarily uncommon.” ...

If you see someone having a seizure or fit, there are some simple things you can do to help.

Identifying childhood epilepsy at an early stage is vital; a late diagnosis can hinder a child's growth and education. Specialists stress that this often-misunderstood brain condition, which faces ...

Many families face the challenge of drug-resistant epilepsy, questioning the transition from medication to surgery.

The Epilepsy Society has welcomed a new experimental treatment for children with Dravet syndrome which researchers say is safe and can help reduce seizures dramatically.

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy. In clinical trials, the treatment zorevunersen cut seizures by as much as 91 ...

A new drug trialled in Sheffield has dramatically reduced seizures in children with a rare and severe form of epilepsy, ...

Early trials led by Great Ormond Street Hospital and UCL found the treatment cut seizures by up to 91% and showed potential benefits for behaviour and development. The findings, published in The New ...